$ORGO
Organogenesis Holdings Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023062056 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $99.65M $108.5M
YoY Change -13.73% -7.13%
Cost Of Revenue $27.77M $25.79M
YoY Change 2.43% -1.48%
Gross Profit $71.88M $82.74M
YoY Change -18.69% -8.76%
Gross Profit Margin 72.13% 76.24%
Selling, General & Admin $61.38M $64.22M
YoY Change -10.12% -19.04%
% of Gross Profit 85.39% 77.62%
Research & Development $11.77M $10.47M
YoY Change 3.29% 9.35%
% of Gross Profit 16.37% 12.65%
Depreciation & Amortization $4.211M $2.544M
YoY Change 53.97% 74.73%
% of Gross Profit 5.86% 3.07%
Operating Expenses $73.15M $74.69M
YoY Change -8.2% -15.98%
Operating Profit -$1.269M $8.050M
YoY Change -114.56% 352.5%
Interest Expense -$502.0K $444.0K
YoY Change -1773.33% -22.38%
% of Operating Profit 5.52%
Other Income/Expense, Net -$25.00K -$413.0K
YoY Change -516.67% -27.16%
Pretax Income -$1.796M $7.637M
YoY Change -120.52% 530.12%
Income Tax -$1.228M $4.470M
% Of Pretax Income 58.53%
Net Earnings -$568.0K $3.167M
YoY Change -107.59% 1373.02%
Net Earnings / Revenue -0.57% 2.92%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.00 $0.02
COMMON SHARES
Basic Shares Outstanding 132.0M 131.3M
Diluted Shares Outstanding 133.4M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $103.8M $98.20M
YoY Change 1.33% -8.44%
Cash & Equivalents $103.8M $98.23M
Short-Term Investments
Other Short-Term Assets $10.95M $10.20M
YoY Change 85.69% 86.2%
Inventory $28.25M $27.91M
Prepaid Expenses $10.45M $9.567M
Receivables $82.00M $89.28M
Other Receivables $0.00 $0.00
Total Short-Term Assets $225.0M $225.6M
YoY Change 1.09% -2.15%
LONG-TERM ASSETS
Property, Plant & Equipment $116.2M $117.5M
YoY Change 13.43% 21.12%
Goodwill $28.77M $28.77M
YoY Change 0.0% 0.0%
Intangibles $15.87M $17.10M
YoY Change -23.66% -22.3%
Long-Term Investments
YoY Change
Other Assets $5.990M $1.321M
YoY Change 294.08% -16.87%
Total Long-Term Assets $235.0M $237.1M
YoY Change 3.63% 4.55%
TOTAL ASSETS
Total Short-Term Assets $225.0M $225.6M
Total Long-Term Assets $235.0M $237.1M
Total Assets $460.0M $462.6M
YoY Change 2.37% 1.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.72M $26.78M
YoY Change -4.97% -29.43%
Accrued Expenses $30.07M $34.99M
YoY Change 13.71% 2.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.567M $6.700M
YoY Change 44.71% 33.89%
Total Short-Term Liabilities $80.51M $81.48M
YoY Change 7.31% -8.73%
LONG-TERM LIABILITIES
Long-Term Debt $62.63M $64.30M
YoY Change -5.43% -4.88%
Other Long-Term Liabilities $1.213M $1.191M
YoY Change 8.11% 9.27%
Total Long-Term Liabilities $1.213M $1.191M
YoY Change 8.11% 9.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.51M $81.48M
Total Long-Term Liabilities $1.213M $1.191M
Total Liabilities $181.4M $185.8M
YoY Change -1.27% -7.55%
SHAREHOLDERS EQUITY
Retained Earnings -$40.97M -$40.40M
YoY Change -9.56% -23.46%
Common Stock $319.6M $317.3M
YoY Change 2.79% 2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.7M $276.9M
YoY Change
Total Liabilities & Shareholders Equity $460.0M $462.6M
YoY Change 2.37% 1.18%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$568.0K $3.167M
YoY Change -107.59% 1373.02%
Depreciation, Depletion And Amortization $4.211M $2.544M
YoY Change 53.97% 74.73%
Cash From Operating Activities $10.61M $16.73M
YoY Change 36.08% 206.8%
INVESTING ACTIVITIES
Capital Expenditures $3.324M $5.980M
YoY Change -68.81% -157.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.324M -$5.980M
YoY Change -68.81% -42.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.777M -1.440M
YoY Change -5.23% -5638.46%
NET CHANGE
Cash From Operating Activities 10.61M 16.73M
Cash From Investing Activities -3.324M -5.980M
Cash From Financing Activities -1.777M -1.440M
Net Change In Cash 5.513M 9.310M
YoY Change -216.53% -289.11%
FREE CASH FLOW
Cash From Operating Activities $10.61M $16.73M
Capital Expenditures $3.324M $5.980M
Free Cash Flow $7.290M $10.75M
YoY Change -355.25% -32.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001661181
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37906
dei Entity Registrant Name
EntityRegistrantName
ORGANOGENESIS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1329150
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Dan Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02021
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
575-0775
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
ORGO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132041164
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98226000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102478000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
599000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
812000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89276000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89450000
CY2023Q3 us-gaap Inventory Net
InventoryNet
27905000
CY2022Q4 us-gaap Inventory Net
InventoryNet
24783000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9567000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5086000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
225573000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
222609000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
117503000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102463000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17101000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20789000
CY2023Q3 us-gaap Goodwill
Goodwill
28772000
CY2022Q4 us-gaap Goodwill
Goodwill
28772000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42363000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43192000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30014000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30014000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1321000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1520000
CY2023Q3 us-gaap Assets
Assets
462647000
CY2022Q4 us-gaap Assets
Assets
449359000
CY2023Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
5483000
us-gaap Revenues
Revenues
335377000
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
4538000
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1174000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13048000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11708000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
26784000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32330000
CY2023Q3 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
34993000
CY2022Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
26447000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
81482000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75023000
CY2023Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
62117000
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
66231000
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2166000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38826000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41314000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1191000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1122000
CY2023Q3 us-gaap Liabilities
Liabilities
185782000
CY2022Q4 us-gaap Liabilities
Liabilities
183690000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132041164
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131647677
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131312616
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
130919129
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
13000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
317254000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
310957000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40402000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45301000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
276865000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
462647000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
449359000
CY2023Q3 us-gaap Revenues
Revenues
108531000
CY2022Q3 us-gaap Revenues
Revenues
116859000
us-gaap Revenues
Revenues
333489000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
25789000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
26177000
us-gaap Cost Of Revenue
CostOfRevenue
78712000
us-gaap Cost Of Revenue
CostOfRevenue
77909000
CY2023Q3 us-gaap Gross Profit
GrossProfit
82742000
CY2022Q3 us-gaap Gross Profit
GrossProfit
90682000
us-gaap Gross Profit
GrossProfit
254777000
us-gaap Gross Profit
GrossProfit
257468000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64222000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79328000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
208373000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
215515000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10470000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9575000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32610000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28367000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
74692000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
88903000
us-gaap Operating Expenses
OperatingExpenses
240983000
us-gaap Operating Expenses
OperatingExpenses
243882000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8050000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1779000
us-gaap Operating Income Loss
OperatingIncomeLoss
13794000
us-gaap Operating Income Loss
OperatingIncomeLoss
13586000
CY2023Q3 us-gaap Interest Expense
InterestExpense
444000
CY2022Q3 us-gaap Interest Expense
InterestExpense
572000
us-gaap Interest Expense
InterestExpense
1688000
us-gaap Interest Expense
InterestExpense
2039000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
82000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-413000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-567000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1606000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2058000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7637000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1212000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12188000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11528000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4470000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
997000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6675000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3482000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3167000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
215000
us-gaap Net Income Loss
NetIncomeLoss
5513000
us-gaap Net Income Loss
NetIncomeLoss
8046000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131312483
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130903160
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131230882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129784890
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133417721
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132232954
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132790296
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132555265
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
271282000
CY2023Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2417000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
3167000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
276865000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-333000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6630000
us-gaap Profit Loss
ProfitLoss
5513000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
276865000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
254385000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-28000
CY2022Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1702000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
215000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
256328000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
241335000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2070000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-648000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
828000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4697000
us-gaap Profit Loss
ProfitLoss
8046000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
256328000
us-gaap Profit Loss
ProfitLoss
5513000
us-gaap Profit Loss
ProfitLoss
8046000
us-gaap Depreciation
Depreciation
7466000
us-gaap Depreciation
Depreciation
4331000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3689000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3662000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5964000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5483000
orgo Non Cash Interest Expense
NonCashInterestExpense
321000
orgo Non Cash Interest Expense
NonCashInterestExpense
326000
orgo Deferred Interest Expense
DeferredInterestExpense
367000
orgo Deferred Interest Expense
DeferredInterestExpense
428000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1320000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
855000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-104000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4412000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-4351000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-7621000
us-gaap Share Based Compensation
ShareBasedCompensation
6630000
us-gaap Share Based Compensation
ShareBasedCompensation
4697000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1761000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11510000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7473000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7282000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4491000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
6282000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
5250000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3661000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5261000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
8179000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-4061000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
68000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
39000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20304000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17059000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21040000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23242000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21040000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23242000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
3281000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
938000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
333000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
648000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2070000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
114000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
200000
orgo Payments Of Deferred Acquisition Consideration
PaymentsOfDeferredAcquisitionConsideration
608000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3728000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-324000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4465000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6507000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103290000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114528000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98825000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108021000
us-gaap Interest Paid Net
InterestPaidNet
3896000
us-gaap Interest Paid Net
InterestPaidNet
1787000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3021000
us-gaap Income Taxes Paid
IncomeTaxesPaid
974000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4146000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5547000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5138000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1708000
orgo Shares Issued For Deferred Acquisition Consideration
SharesIssuedForDeferredAcquisitionConsideration
828000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40402000
CY2023Q3 orgo Working Capital
WorkingCapital
144091000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98226000
us-gaap Revenues
Revenues
333489000
us-gaap Net Income Loss
NetIncomeLoss
5513000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20304000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported results of operations during</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the reporting periods. In preparing the condensed consolidated financial statements, the estimates and assumptions that management consider to be significant and that present the greatest amount of uncertainty include: revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived and indefinite lived assets (including intangible assets); assessing impairment of goodwill; and</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. The Company invests its cash equivalents in highly rated money market funds. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). However, the Company sweeps cash daily overnight and diversifies among financial institutions to reduce such exposure.</span></p>
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3782000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2023Q3 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1393000
CY2022Q3 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1183000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
4282000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
5136000
CY2023Q3 us-gaap Revenues
Revenues
108531000
CY2022Q3 us-gaap Revenues
Revenues
116859000
us-gaap Revenues
Revenues
333489000
us-gaap Revenues
Revenues
335377000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3782000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
96829000
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
95812000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7553000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6362000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89276000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89450000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6651000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5022000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6362000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5153000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1130000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
733000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1320000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
855000
CY2023Q3 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-228000
CY2022Q3 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-177000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-744000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-430000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7553000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5578000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7553000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5578000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13908000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12282000
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1341000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1022000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12656000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11479000
CY2023Q3 us-gaap Inventory Net
InventoryNet
27905000
CY2022Q4 us-gaap Inventory Net
InventoryNet
24783000
CY2023Q3 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
887000
CY2022Q3 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
2393000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
4351000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
7621000
CY2023Q3 orgo Prepaid Subscription
PrepaidSubscription
6778000
CY2022Q4 orgo Prepaid Subscription
PrepaidSubscription
4211000
CY2023Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
764000
CY2022Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
106000
CY2023Q3 orgo Prepaid Deposits
PrepaidDeposits
934000
CY2022Q4 orgo Prepaid Deposits
PrepaidDeposits
635000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
1054000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
54000
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
37000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
80000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9567000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5086000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
128329000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
99697000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70243000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62798000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
117503000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102463000
CY2023Q3 us-gaap Depreciation
Depreciation
2544000
CY2022Q3 us-gaap Depreciation
Depreciation
1456000
us-gaap Depreciation
Depreciation
7466000
us-gaap Depreciation
Depreciation
4331000
orgo Sale And Donation Charges Of Equipment Related To Construction In Progress
SaleAndDonationChargesOfEquipmentRelatedToConstructionInProgress
4200000
CY2022Q3 orgo Sale And Donation Charges Of Equipment Related To Construction In Progress
SaleAndDonationChargesOfEquipmentRelatedToConstructionInProgress
4200000
orgo Cancellation Fees Related To Pause Of Construction Of Manufacturing Facility
CancellationFeesRelatedToPauseOfConstructionOfManufacturingFacility
632000
CY2022Q3 orgo Cancellation Fees Related To Pause Of Construction Of Manufacturing Facility
CancellationFeesRelatedToPauseOfConstructionOfManufacturingFacility
632000
CY2023Q3 us-gaap Goodwill
Goodwill
28772000
CY2022Q4 us-gaap Goodwill
Goodwill
28772000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
41422000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17101000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37734000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20789000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1230000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1220000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3689000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3662000
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
3168000
us-gaap Restructuring Charges
RestructuringCharges
1518000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1192000
us-gaap Restructuring Charges
RestructuringCharges
1878000
us-gaap Payments For Restructuring
PaymentsForRestructuring
3056000
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
14000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22433000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17113000
CY2023Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2862000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3320000
CY2023Q3 orgo Accrued Interest On Accrued But Unpaid Lease Obligations
AccruedInterestOnAccruedButUnpaidLeaseObligations
2204000
CY2022Q4 orgo Accrued Interest On Accrued But Unpaid Lease Obligations
AccruedInterestOnAccruedButUnpaidLeaseObligations
2463000
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
6185000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2625000
CY2023Q3 orgo Accrued Litigation Current
AccruedLitigationCurrent
564000
CY2022Q4 orgo Accrued Litigation Current
AccruedLitigationCurrent
150000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
745000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
776000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34993000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26447000
CY2023Q1 orgo Number Of Reduction In Employees
NumberOfReductionInEmployees
71
CY2023Q1 orgo Percentage Of Reduction In Employees
PercentageOfReductionInEmployees
0.07
us-gaap Severance Costs1
SeveranceCosts1
1609000
CY2023Q3 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-95000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
611000
us-gaap Restructuring Charges
RestructuringCharges
1878000
us-gaap Restructuring Charges
RestructuringCharges
1518000
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
14000
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1110000
us-gaap Payments For Restructuring
PaymentsForRestructuring
3576000
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
1110000
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
0
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q3 us-gaap Secured Debt
SecuredDebt
67969000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
71250000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
369000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
481000
CY2023Q3 orgo Secured Debt Net
SecuredDebtNet
67600000
CY2022Q4 orgo Secured Debt Net
SecuredDebtNet
70769000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1406000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5625000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6563000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
54375000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
67969000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2.51
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
8.03
CY2023Q3 orgo Fair Value Of Common Share
FairValueOfCommonShare
2.47
CY2023Q3 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
9370314
CY2022Q4 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
5931742
CY2023Q3 orgo Sharesreservedforissuanceforoutstandingrestrictedstockunits
Sharesreservedforissuanceforoutstandingrestrictedstockunits
3969953
CY2022Q4 orgo Sharesreservedforissuanceforoutstandingrestrictedstockunits
Sharesreservedforissuanceforoutstandingrestrictedstockunits
1381500
CY2023Q3 orgo Shares Reserved For Issuance For Future Grant
SharesReservedForIssuanceForFutureGrant
4924835
CY2022Q4 orgo Shares Reserved For Issuance For Future Grant
SharesReservedForIssuanceForFutureGrant
11394962
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18265102
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18708204
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1418224
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0399
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0192
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5066
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 orgo Fair Value Of Common Share
FairValueOfCommonShare
7.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.94
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5931042
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.91
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2245000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
82981
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.25
orgo Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Forfeited In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledAndForfeitedInPeriodIntrinsicValue
10000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
32275
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.49
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9370314
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M1D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5308000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4005419
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.58
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M2D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2936000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8362789
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y7M28D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
4801000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3117000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2082000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
3167000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
215000
us-gaap Profit Loss
ProfitLoss
5513000
us-gaap Profit Loss
ProfitLoss
8046000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131312483
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130903160
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131230882
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129784890
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133417721
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132232954
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132790296
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132555265
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2019Q2 orgo Interest Rate On Unpaid Lease Obligations
InterestRateOnUnpaidLeaseObligations
0.0925
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
192000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
213000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
41000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000
orgo Finance Lease Cost
FinanceLeaseCost
233000
orgo Finance Lease Cost
FinanceLeaseCost
220000
us-gaap Operating Lease Cost
OperatingLeaseCost
7387000
us-gaap Operating Lease Cost
OperatingLeaseCost
7197000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
2307000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
2180000
us-gaap Variable Lease Cost
VariableLeaseCost
4867000
us-gaap Variable Lease Cost
VariableLeaseCost
3564000
us-gaap Lease Cost
LeaseCost
14794000
us-gaap Lease Cost
LeaseCost
13161000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
4625000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1174000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1366000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1174000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3259000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
3340000
us-gaap Operating Lease Payments
OperatingLeasePayments
7718000
us-gaap Operating Lease Payments
OperatingLeasePayments
6964000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
41000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
7000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
114000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
200000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5138000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1708000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
3451000
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M2D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M4D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y6M14D
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0795
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0473
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0461
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7864000
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
434000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
9357000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
1278000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
8938000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
1278000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
7542000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
737000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
8002000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
18678000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
60381000
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3727000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8507000
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
387000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
51874000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
3340000
CY2023Q3 orgo Accrued Legal Expenses
AccruedLegalExpenses
564000
CY2022Q4 orgo Accrued Legal Expenses
AccruedLegalExpenses
150000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6675000
orgo Discreet Tax Expense
DiscreetTaxExpense
68000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3482000
orgo Discreet Tax Expense
DiscreetTaxExpense
39000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-062056-index-headers.html Edgar Link pending
0000950170-23-062056-index.html Edgar Link pending
0000950170-23-062056.txt Edgar Link pending
0000950170-23-062056-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orgo-20230930.htm Edgar Link pending
orgo-20230930.xsd Edgar Link pending
orgo-ex31_1.htm Edgar Link pending
orgo-ex31_2.htm Edgar Link pending
orgo-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
orgo-20230930_def.xml Edgar Link unprocessable
orgo-20230930_lab.xml Edgar Link unprocessable
orgo-20230930_pre.xml Edgar Link unprocessable
orgo-20230930_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
orgo-20230930_cal.xml Edgar Link unprocessable